Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces its participation in the 27th Annual American Society of Cell and Gene Therapy Meeting, taking place on May 7-11, 2024, in Baltimore, United States of America.
